XML 110 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net loss $ (58,334) $ (81,847) $ (105,254)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 123,768 125,846 126,443
Impairment charges 26,148 28,661 31,604
Inventory write-down 0 0 525
Loss on extinguishment of debt 0 748 842
Deferred income tax benefit (11,713) (31,403) (8,976)
Non-cash compensation charge 10,116 11,036 7,338
Gain on disposals of assets (3,882) (1,606) (825)
Provision (benefit) for loss on receivables, net of recoveries (30) (276) 51
Other, net 2,659 4,879 3,871
Changes in operating assets and liabilities:      
Accounts receivable (20,547) 13,326 (6,896)
Inventories (87) 3,376 (4,463)
Accounts payable and accrued liabilities 8,473 (17,716) 12,674
Taxes payable (75) 5,310 3,210
Other current assets and liabilities, net (2,015) (5,943) (3,318)
Net cash flows provided by operating activities 74,481 54,391 56,826
Cash flows from investing activities:      
Capital expenditures (29,812) (17,108) (11,194)
Payments related to acquisitions, net of cash acquired (16,434) (171,337) 0
Proceeds from disposition of property, plant and equipment 5,906 5,844 1,908
Other, net 1,762 654 548
Net cash flows used in investing activities (38,578) (181,947) (8,738)
Cash flows from financing activities:      
Proceeds from issuance of common shares, net 0 0 64,734
Revolving credit borrowings 381,615 358,312 44,525
Revolving credit repayments (385,071) (217,339) (84,462)
Term loan repayments (34,942) (26,609) (40,781)
Debt issuance costs (1,950) (4,009) (1,795)
Other, net (4,283) (832) (293)
Net cash flows provided by (used in) financing activities (44,631) 109,523 (18,072)
Effect of exchange rate changes on cash (313) (2,242) 846
Net change in cash and cash equivalents (9,041) (20,275) 30,862
Cash and cash equivalents, beginning of period 12,372 32,647 1,785
Cash and cash equivalents, end of period 3,331 12,372 32,647
Non-cash investing and financing items      
Preferred dividends paid-in-kind 1,849 1,459 0
Common Shares      
Non-cash investing and financing items      
Value of shares issued as consideration for acquisitions 0 119,797 0
Preferred Shares      
Non-cash investing and financing items      
Value of shares issued as consideration for acquisitions $ 0 $ 54,821 $ 0